annual CFF:
$255.87M-$390.53M(-60.42%)Summary
- As of today (May 21, 2025), PTCT annual cash flow from financing activities is $255.87 million, with the most recent change of -$390.53 million (-60.42%) on December 31, 2024.
- During the last 3 years, PTCT annual CFF has risen by +$234.99 million (+1125.59%).
- PTCT annual CFF is now -61.74% below its all-time high of $668.72 million, reached on December 31, 2020.
Performance
PTCT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$9.41M-$17.06M(-64.45%)Summary
- As of today (May 21, 2025), PTCT quarterly cash flow from financing activities is $9.41 million, with the most recent change of -$17.06 million (-64.45%) on March 1, 2025.
- Over the past year, PTCT quarterly CFF has increased by +$8.87 million (+1642.59%).
- PTCT quarterly CFF is now -98.54% below its all-time high of $643.05 million, reached on September 30, 2020.
Performance
PTCT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$264.74M+$8.87M(+3.47%)Summary
- As of today (May 21, 2025), PTCT TTM cash flow from financing activities is $264.74 million, with the most recent change of +$8.87 million (+3.47%) on March 1, 2025.
- Over the past year, PTCT TTM CFF has dropped by -$378.11 million (-58.82%).
- PTCT TTM CFF is now -69.60% below its all-time high of $870.87 million, reached on June 30, 2024.
Performance
PTCT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PTCT Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.4% | +1642.6% | -58.8% |
| 3 y3 years | +1125.6% | +705.6% | +2015.5% |
| 5 y5 years | -58.3% | -49.1% | -34.8% |
PTCT Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.4% | +1125.6% | -98.5% | +106.7% | -69.6% | +302.7% |
| 5 y | 5-year | -61.7% | +1125.6% | -98.5% | +106.7% | -69.6% | +302.7% |
| alltime | all time | -61.7% | +3663.7% | -98.5% | +106.7% | -69.6% | +302.7% |
PTCT Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $9.41M(-64.5%) | $264.74M(+3.5%) |
| Dec 2024 | $255.87M(-60.4%) | $26.47M(-250.2%) | $255.87M(-69.9%) |
| Sep 2024 | - | -$17.63M(-107.2%) | $849.88M(-2.4%) |
| Jun 2024 | - | $246.48M(>+9900.0%) | $870.87M(+35.5%) |
| Mar 2024 | - | $540.00K(-99.9%) | $642.85M(-0.5%) |
| Dec 2023 | $646.40M(+284.9%) | $620.49M(>+9900.0%) | $646.40M(+96.6%) |
| Sep 2023 | - | $3.36M(-81.8%) | $328.83M(+77.3%) |
| Jun 2023 | - | $18.46M(+350.9%) | $185.48M(+8.5%) |
| Mar 2023 | - | $4.09M(-98.6%) | $170.88M(+1.7%) |
| Dec 2022 | $167.95M(+704.5%) | $302.92M(-316.4%) | $167.95M(-228.6%) |
| Sep 2022 | - | -$140.00M(-3725.9%) | -$130.61M(-1156.8%) |
| Jun 2022 | - | $3.86M(+230.6%) | $12.36M(-1.2%) |
| Mar 2022 | - | $1.17M(-73.2%) | $12.51M(-40.1%) |
| Dec 2021 | $20.88M(-96.9%) | $4.35M(+46.3%) | $20.88M(-63.1%) |
| Sep 2021 | - | $2.98M(-25.9%) | $56.61M(-91.9%) |
| Jun 2021 | - | $4.02M(-57.9%) | $696.69M(+5.6%) |
| Mar 2021 | - | $9.53M(-76.2%) | $659.76M(-1.3%) |
| Dec 2020 | $668.72M(+9.1%) | $40.09M(-93.8%) | $668.72M(+6.0%) |
| Sep 2020 | - | $643.05M(-2053.5%) | $630.91M(+70.4%) |
| Jun 2020 | - | -$32.92M(-278.0%) | $370.21M(-8.8%) |
| Mar 2020 | - | $18.49M(+709.5%) | $405.98M(-33.8%) |
| Dec 2019 | $613.21M(+366.1%) | $2.28M(-99.4%) | $613.21M(-0.2%) |
| Sep 2019 | - | $382.35M(>+9900.0%) | $614.65M(+158.9%) |
| Jun 2019 | - | $2.85M(-98.7%) | $237.38M(-33.4%) |
| Mar 2019 | - | $225.72M(+5958.0%) | $356.16M(+170.7%) |
| Dec 2018 | $131.57M | $3.73M(-26.7%) | $131.57M(+1.4%) |
| Sep 2018 | - | $5.08M(-95.8%) | $129.70M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $121.63M(>+9900.0%) | $126.32M(+182.7%) |
| Mar 2018 | - | $1.14M(-38.6%) | $44.69M(+1.1%) |
| Dec 2017 | $44.22M(+4468.0%) | $1.85M(+8.4%) | $44.22M(+4.3%) |
| Sep 2017 | - | $1.71M(-95.7%) | $42.41M(+2.0%) |
| Jun 2017 | - | $40.00M(+5932.7%) | $41.59M(+2504.5%) |
| Mar 2017 | - | $663.00K(+1478.6%) | $1.60M(+65.0%) |
| Dec 2016 | $968.00K(-99.4%) | $42.00K(-95.3%) | $968.00K(+2.1%) |
| Sep 2016 | - | $892.00K(>+9900.0%) | $948.00K(-99.4%) |
| Jun 2016 | - | $0.00(-100.0%) | $146.02M(-3.3%) |
| Mar 2016 | - | $34.00K(+54.5%) | $151.08M(-1.9%) |
| Dec 2015 | $154.06M(-35.0%) | $22.00K(-100.0%) | $154.06M(-43.5%) |
| Sep 2015 | - | $145.97M(+2788.7%) | $272.44M(+114.8%) |
| Jun 2015 | - | $5.05M(+67.4%) | $126.83M(+4.0%) |
| Mar 2015 | - | $3.02M(-97.5%) | $122.00M(-48.6%) |
| Dec 2014 | $237.13M(+26.5%) | $118.40M(>+9900.0%) | $237.13M(+99.8%) |
| Sep 2014 | - | $359.00K(+64.7%) | $118.69M(+2.8%) |
| Jun 2014 | - | $218.00K(-99.8%) | $115.47M(-53.8%) |
| Mar 2014 | - | $118.15M(<-9900.0%) | $250.20M(+33.5%) |
| Dec 2013 | $187.44M(+736.4%) | -$36.00K(-98.7%) | $187.44M(+0.4%) |
| Sep 2013 | - | -$2.86M(-102.1%) | $186.77M(-0.7%) |
| Jun 2013 | - | $134.94M(+143.6%) | $188.05M(+134.7%) |
| Mar 2013 | - | $55.39M(-7972.2%) | $80.13M(+257.5%) |
| Dec 2012 | $22.41M(-412.1%) | -$703.60K(-55.4%) | $22.41M(-3.0%) |
| Sep 2012 | - | -$1.58M(-105.8%) | $23.11M(-6.4%) |
| Jun 2012 | - | $27.02M(-1259.5%) | $24.69M(-1159.5%) |
| Mar 2012 | - | -$2.33M | -$2.33M |
| Dec 2011 | -$7.18M | - | - |
FAQ
- What is PTC Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for PTC Therapeutics?
- What is PTC Therapeutics annual CFF year-on-year change?
- What is PTC Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for PTC Therapeutics?
- What is PTC Therapeutics quarterly CFF year-on-year change?
- What is PTC Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for PTC Therapeutics?
- What is PTC Therapeutics TTM CFF year-on-year change?
What is PTC Therapeutics annual cash flow from financing activities?
The current annual CFF of PTCT is $255.87M
What is the all time high annual CFF for PTC Therapeutics?
PTC Therapeutics all-time high annual cash flow from financing activities is $668.72M
What is PTC Therapeutics annual CFF year-on-year change?
Over the past year, PTCT annual cash flow from financing activities has changed by -$390.53M (-60.42%)
What is PTC Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of PTCT is $9.41M
What is the all time high quarterly CFF for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash flow from financing activities is $643.05M
What is PTC Therapeutics quarterly CFF year-on-year change?
Over the past year, PTCT quarterly cash flow from financing activities has changed by +$8.87M (+1642.59%)
What is PTC Therapeutics TTM cash flow from financing activities?
The current TTM CFF of PTCT is $264.74M
What is the all time high TTM CFF for PTC Therapeutics?
PTC Therapeutics all-time high TTM cash flow from financing activities is $870.87M
What is PTC Therapeutics TTM CFF year-on-year change?
Over the past year, PTCT TTM cash flow from financing activities has changed by -$378.11M (-58.82%)